ClinicalTrials.Veeva

Menu

Effectiveness of Narrow Margins in Patients With Low-Risk Basal Cell Carcinoma Undergoing Surgery

S

Sidney Kimmel Cancer Center at Thomas Jefferson University

Status

Completed

Conditions

Skin Basal Cell Carcinoma

Treatments

Procedure: Therapeutic Conventional Surgery

Study type

Interventional

Funder types

Other

Identifiers

NCT02579551
JT 2143 (Other Identifier)
NCI-2015-01624 (Registry Identifier)
11D.479

Details and patient eligibility

About

This clinical trial studies the effectiveness of narrow margins in patients with low-risk basal cell carcinoma undergoing surgery to remove skin lesions on the face. A margin is the area of normal tissue around a tumor taken out during surgery to make sure all of the cancer is removed. This clinical trial studies tissue samples to determine the least amount of tissue that must be removed to give an acceptable cure rate. This may allow less normal tissue to be removed from patients and may be a less expensive surgery.

Full description

PRIMARY OBJECTIVES:

I. To determine the success rate of narrow margin excisions of low-risk facial basal cell carcinoma (BCC).

SECONDARY OBJECTIVES:

I. To determine the narrowest excision margin for low-risk facial BCC that gives an acceptable (95%) cure rate over a 3 year follow-up period.

Enrollment

179 patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Location

    1. Area M (cheeks, forehead, scalp & neck) tumor size < 10 mm
    2. Area H (central face, eyelids, eyebrows, periorbital, nose, lips, chin, mandible, preauricular & postauricular, temple & ear) tumor size < 6 mm
  2. Well-defined borders

  3. Primary BCC

  4. Patient is not immunosuppressed

  5. There has not been prior radiotherapy to the site

  6. Nodular subtype

  7. No perineural involvement-(no neurological deficits grossly) -

Exclusion criteria

  1. Location

    1. Area M tumor size > or = to 10 mm
    2. Area H tumor size > or = to 6 mm
  2. Poorly defined borders

  3. Recurrent BCC

  4. Patient is immunosuppressed

  5. There has been prior radiotherapy to the site -

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

179 participants in 1 patient group

Treatment (surgical excision)
Experimental group
Description:
Patients undergo surgical excision of the skin lesion consisting of 1 and 2 mm circumferential margins during visit 1.
Treatment:
Procedure: Therapeutic Conventional Surgery

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems